- Home
- Applications
- north america
- stem cell
Show results for
Refine by
Stem Cell Product Applications In North America
24 applications found
BOC Sciences provides a wide range of research chemicals and biochemicals including inhibitors, Stem Cell Molecule and chiral compounds.https://www.bocsci.com/cyclosporin-h-cas-83602-39-5-item-78163.html ...
ByBOC Sciences based in Shirley, NEW YORK (USA)
BOC Sciences provides a wide range of research chemicals and biochemicals including inhibitors, Stem Cell Molecule and chiral compounds.https://www.bocsci.com/noribogaine-hcl-cas-110514-35-7-item-472290.html ...
ByBOC Sciences based in Shirley, NEW YORK (USA)
BOC Sciences provides a wide range of research chemicals and biochemicals including inhibitors, ADCs, Stem Cell Molecule and chiral compounds.https://www.bocsci.com/cyclosporin-b-cas-63775-95-1-item-74128.html ...
ByBOC Sciences based in Shirley, NEW YORK (USA)
BOC Sciences provides a wide range of research chemicals and biochemicals including inhibitors, Stem Cell Molecule and chiral compounds.https://www.bocsci.com/ramelteon-impurity-d-cas-880152-61-4-item-462124.html ...
ByBOC Sciences based in Shirley, NEW YORK (USA)
BOC Sciences provides a wide range of research chemicals and biochemicals including inhibitors, Stem Cell Molecule and chiral compounds.https://www.bocsci.com/ramelteon-impurity-f-cas-196597-17-8-item-172938.html ...
ByBOC Sciences based in Shirley, NEW YORK (USA)
BOC Sciences provides a wide range of research chemicals and biochemicals including inhibitors, ADCs, Stem Cell Molecule and chiral compounds.https://www.bocsci.com/clopidogrel-related-compound-a-cas-144750-42-5-item-166517.html ...
ByBOC Sciences based in Shirley, NEW YORK (USA)
BOC Sciences provides a wide range of research chemicals and biochemicals including inhibitors, building blocks, Stem Cell Molecule and chiral compounds.https://www.bocsci.com/cyclosporin-c-cas-59787-61-0-item-72656.html ...
ByBOC Sciences based in Shirley, NEW YORK (USA)
BOC Sciences provides a wide range of research chemicals and biochemicals including inhibitors, building blocks, Stem Cell Molecule and chiral compounds.https://www.bocsci.com/ramelteon-impurity-e-cas-196597-16-7-item-458799.html ...
ByBOC Sciences based in Shirley, NEW YORK (USA)
BOC Sciences provides a wide range of research chemicals and biochemicals including inhibitors, ADCs, Stem Cell Molecule and chiral compounds.https://www.bocsci.com/cyclosporin-d-cas-63775-96-2-item-74129.html ...
ByBOC Sciences based in Shirley, NEW YORK (USA)
Our RASTRUM matrices support a range of stem cell types and allow for their growth and ...
ByInventia Life Science Pty Ltd (ILS) based in Alexandria, AUSTRALIA
Following extensive research and development, Biostage has evolved its technology to optimize the interaction of mesenchymal stem cells seeded on a biocompatible scaffold. Preclinical studies suggest that, once implanted, the scaffold seeded with the patient’s own cells signals the stem cell niche to guide the regeneration of a biological ...
ByHarvard Apparatus Regenerative Technology, Inc. formely known as Biostage, Inc. based in Holliston, MASSACHUSETTS (USA)
i-FACTOR Bone Graft facilitates the ingrowth of bone by promoting the migration of mesenchymal stem cells and other progenitor cells from surrounding ...
ByCerapedics, Inc. based in Westminster, COLORADO (USA)
Isolating edited-pluripotent stem cells with traditional sorting techniques can subject the cells to rough conditions in which gene expression, genomic stability and overall cell-health can become compromised. Microfluidic cell sorting with the WOLF, along with single cell deposition using the N1 single cell dispenser, eliminates the challenges that pluripotent stem ...
ByNanoCellect Biomedical, Inc. based in San Diego, CALIFORNIA (USA)
Growth performance of human adipose-derived mesenchymal stem cells in media containing Simplified Platelet Lysate (SimPL) and fetal bovine serum (FBS). Cells were grown in standard DMEM/F12 basal media containing penicillin, streptomycin, and GlutaMAX™ with either 10% (v/v) FBS or 2% SimPL (left). Similarly, cells were grown in identical conditions except for the use of reduced-serum basal media (Gibco™ Advanced DMEM/F12) with either ...
ByAgulos Biotech, LLC based in Lake Mills, WISCONSIN (USA)
Generating cell lines has often been inefficient and affected by inaccurate limited dilution methods or the shear stress caused by conventional flow cytometer and traditional high-pressure cell sorters. NanoCellect Biomedical provides cell sorting solutions that allow to sort cells and establish stable cell lines using gentle low-pressure microfluidics. The WOLF’s ability to protect cell viability after ...
ByNanoCellect Biomedical, Inc. based in San Diego, CALIFORNIA (USA)
Over the years, we have designed and constructed modular facilities over a vast array of industries including: Biotechnology, Agricultural Biotechnology, Pharmaceutical packaging, Medical Device Packaging, and Stem Cell ...
ByBiologics Modular, LLC based in Brownsburg, INDIANA (USA)
Over the years, we have designed and constructed modular facilities over a vast array of industries including: Biotechnology, Agricultural Biotechnology, Pharmaceutical packaging, Medical Device Packaging, and Stem Cell ...
ByBiologics Modular, LLC based in Brownsburg, INDIANA (USA)
BOC Sciences is committed to supplying cost-effective products and services. We provide Brassinolide (Cas No:72962-43-7). More information, please visit the website: http://www.bocsci.com/brassinolide-cas-72962-43-7-item-84-97657.html ...
ByBOC Sciences based in Shirley, NEW YORK (USA)
In cell therapy, the source and quality of albumin has proven important for both performance and regulatory purposes. Albumedix' recombinant human albumin products are used in a range of cell therapy media and products offering increased viability, consistency and ...
BySartorius AG based in Goettingen, GERMANY
Fractyl Health was founded in 2011 with a dedication to developing novel therapeutic interventions that have the potential to help reverse the metabolic disease epidemic. Despite advances in treatment over the past 50 years, metabolic diseases in general, and type 2 diabetes (T2D) in particular, continue to be a principal and rapidly growing driver of morbidity and mortality in the 21st century. Our goal is to transform T2D treatment from chronic blood glucose management to disease-modifying therapies that target ...
ByFractyl Health based in Lexington, MASSACHUSETTS (USA)